Skip to main content

Table 3 Immune-related markers and mechanism analysis of PIWIL4 and SUPT5H

From: PIWIL4 and SUPT5H combine to predict prognosis and immune landscape in intrahepatic cholangiocarcinoma

Gene Types Target Spearman correlation analysis p value Survival p value
PIWIL4 Chemokin CCL24 − 0.434 p < 0.001   p = 0.00626
  receptor CCR9 0.344 0.0408   
SUPT5H Chemokin CXCL5 − 0.419 0.0116   p = 0.0234
   CXCL12 0.405 0.0148   
   CXCL16 − 0.359 0.0321   
  Immunoinhibitor IL10RB 0.44 0.00775   
   PVRL2 0.52 0.00133   
  Immunostimulator CD276 0.357 0.0331   
   CXCL12 0.405 0.0148   
   ENTPD1 − 0.364 0.0297   
   TMEM173 − 0.334 0.0473   
   TNFSF4 − 0.337 0.0447   
   TNFSF13 − 0.382 0.0222   
  CHOL_MHC HLA-DOB − 0.367 0.0282   
  CHOL_TIL_TEM Tem CD4 cells − 0.349 0.0376   
  CHOL_TIL_Th2 Th2 cells     
  CHOL_TIL_Th17 Th17 cells − 0.421 0.0112   
PIWIL4      
Cancer type Drug Group Res vs N-Res Log2(FC) p value
Melanoma Anti-PD-1(pembrolizumab and nivolumab) All 14 vs 12 − 0.524 0.0385
  1. Res The numbers of responders, NRes The numbers of non-responders